Peter Pfreundschuh
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Pfreundschuh
Peter Pfreundschuh was last confirmed as CFO at UroGen Pharma Ltd. (URGN) in a filing dated April 28, 2021. Earlier roles on record: CFO at UroGen Pharma Ltd. (URGN) until October 15, 2020. The proxy statement of UroGen Pharma Ltd. reports total compensation of $1,163,956 for Peter Pfreundschuh in fiscal 2020, including a base salary of $324,329. Disclosed compensation is on record for 3 fiscal years. Peter Pfreundschuh has spoken on 2 earnings calls across 1 company, most recently for UroGen Pharma Ltd. on August 10, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2020-10-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | $324,329 | $1,163,956 |
| 2019 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | $435,625 | $1,346,791 |
| 2018 | UroGen Pharma Ltd. (URGN) | Chief Financial Officer | $156,424 | $2,485,800 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.